Abstract

Crosstalk between different receptor tyrosine kinases (RTKs) is thought to drive oncogenic signaling and allow therapeutic escape. EGFR and RON are two such RTKs from different subfamilies, which engage in crosstalk through unknown mechanisms. We combined high-resolution imaging with biochemical and mutational studies to ask how EGFR and RON communicate. EGF stimulation promotes EGFR-dependent phosphorylation of RON, but ligand stimulation of RON does not trigger EGFR phosphorylation – arguing that crosstalk is unidirectional. Nanoscale imaging reveals association of EGFR and RON in common plasma membrane microdomains. Two-color single particle tracking captured formation of complexes between RON and EGF-bound EGFR. Our results further show that RON is a substrate for EGFR kinase, and that transactivation of RON requires formation of a signaling competent EGFR dimer. These results support a role for direct EGFR/RON interactions in propagating crosstalk, such that EGF-stimulated EGFR phosphorylates RON to activate RON-directed signaling.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data for the quantitative plots and gels have been provided.

Article and author information

Author details

  1. Carolina Franco Nitta

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9122-5453
  2. Ellen W Green

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2083-522X
  3. Elton D Jhamba

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Justine M Keth

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Iraís Ortiz-Caraveo

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Rachel M Grattan

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. David J Schodt

    Department of Physics and Astronomy, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8986-2736
  8. Aubrey C Gibson

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Ashwani Rajput

    Department of Surgery, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Keith Lidke

    Department of Physics & Astronomy, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Bridget S Wilson

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Mara P Steinkamp

    Department of Pathology, University of New Mexico, Albuquerque, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Diane S Lidke

    Department of Pathology, University of New Mexico, Albuquerque, United States
    For correspondence
    dlidke@salud.unm.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8533-6029

Funding

National Institutes of Health (R35GM126934)

  • Diane S Lidke

National Institutes of Health (R21GM132716)

  • Keith Lidke

National Institutes of Health (New Mexico Spatiotemporal Modeling Center,P50GM085273)

  • Bridget S Wilson
  • Diane S Lidke

National Institutes of Health (UNM MARC Program,2T34GM008751)

  • Justine M Keth

National Institutes of Health (ASERT-IRACDA,K12GM088021)

  • Elton D Jhamba

National Institutes of Health (UNM Undergraduate Pipeline Network,P30CA118100)

  • Justine M Keth
  • Aubrey C Gibson

National Institutes of Health (R01CA248166)

  • Diane S Lidke

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Franco Nitta et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,345
    views
  • 188
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Carolina Franco Nitta
  2. Ellen W Green
  3. Elton D Jhamba
  4. Justine M Keth
  5. Iraís Ortiz-Caraveo
  6. Rachel M Grattan
  7. David J Schodt
  8. Aubrey C Gibson
  9. Ashwani Rajput
  10. Keith Lidke
  11. Bridget S Wilson
  12. Mara P Steinkamp
  13. Diane S Lidke
(2021)
EGFR transactivates RON to drive oncogenic crosstalk
eLife 10:e63678.
https://doi.org/10.7554/eLife.63678

Share this article

https://doi.org/10.7554/eLife.63678

Further reading

    1. Cell Biology
    Fatima Tleiss, Martina Montanari ... C Leopold Kurz
    Research Article

    Multiple gut antimicrobial mechanisms are coordinated in space and time to efficiently fight foodborne pathogens. In Drosophila melanogaster, production of reactive oxygen species (ROS) and antimicrobial peptides (AMPs) together with intestinal cell renewal play a key role in eliminating gut microbes. A complementary mechanism would be to isolate and treat pathogenic bacteria while allowing colonization by commensals. Using real-time imaging to follow the fate of ingested bacteria, we demonstrate that while commensal Lactiplantibacillus plantarum freely circulate within the intestinal lumen, pathogenic strains such as Erwinia carotovora or Bacillus thuringiensis, are blocked in the anterior midgut where they are rapidly eliminated by antimicrobial peptides. This sequestration of pathogenic bacteria in the anterior midgut requires the Duox enzyme in enterocytes, and both TrpA1 and Dh31 in enteroendocrine cells. Supplementing larval food with hCGRP, the human homolog of Dh31, is sufficient to block the bacteria, suggesting the existence of a conserved mechanism. While the immune deficiency (IMD) pathway is essential for eliminating the trapped bacteria, it is dispensable for the blockage. Genetic manipulations impairing bacterial compartmentalization result in abnormal colonization of posterior midgut regions by pathogenic bacteria. Despite a functional IMD pathway, this ectopic colonization leads to bacterial proliferation and larval death, demonstrating the critical role of bacteria anterior sequestration in larval defense. Our study reveals a temporal orchestration during which pathogenic bacteria, but not innocuous, are confined in the anterior part of the midgut in which they are eliminated in an IMD-pathway-dependent manner.

    1. Cell Biology
    Yue Miao, Yongtao Du ... Mei Ding
    Research Article

    The spatiotemporal transition of small GTPase Rab5 to Rab7 is crucial for early-to-late endosome maturation, yet the precise mechanism governing Rab5-to-Rab7 switching remains elusive. USP8, a ubiquitin-specific protease, plays a prominent role in the endosomal sorting of a wide range of transmembrane receptors and is a promising target in cancer therapy. Here, we identified that USP8 is recruited to Rab5-positive carriers by Rabex5, a guanine nucleotide exchange factor (GEF) for Rab5. The recruitment of USP8 dissociates Rabex5 from early endosomes (EEs) and meanwhile promotes the recruitment of the Rab7 GEF SAND-1/Mon1. In USP8-deficient cells, the level of active Rab5 is increased, while the Rab7 signal is decreased. As a result, enlarged EEs with abundant intraluminal vesicles accumulate and digestive lysosomes are rudimentary. Together, our results reveal an important and unexpected role of a deubiquitinating enzyme in endosome maturation.